Clinical Trials Browser

Phase 1 × Precancerous Conditions × BF-200 ALA × Clear all

NCT05060237 2024-10-17

Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp

Phase 1 Completed

112 enrolled 21 charts

DermatologicOther neoplasm

Keratosis, Precancerous Conditions, Skin Diseases, Keratosis, Actinic